187 related articles for article (PubMed ID: 15188075)
1. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Mita E; Ohkawa K; Katayama K; Fusamoto H; Kamada T
Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
[TBL] [Abstract][Full Text] [Related]
3. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
Karino Y; Toyota J; Sugawara M; Higashino K; Sato T; Ohmura T; Suga T; Okuuchi Y; Matsushima T
Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
[TBL] [Abstract][Full Text] [Related]
4. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
[TBL] [Abstract][Full Text] [Related]
5. Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
Martinot-Peignoux M; Marcellin P; Pouteau M; Castelnau C; Boyer N; Poliquin M; Degott C; Descombes I; Le Breton V; Milotova V
Hepatology; 1995 Oct; 22(4 Pt 1):1050-6. PubMed ID: 7557850
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
[TBL] [Abstract][Full Text] [Related]
8. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
Enomoto N; Sakuma I; Asahina Y; Kurosaki M; Murakami T; Yamamoto C; Ogura Y; Izumi N; Marumo F; Sato C
N Engl J Med; 1996 Jan; 334(2):77-81. PubMed ID: 8531962
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
[TBL] [Abstract][Full Text] [Related]
11. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
12. Differential flotation centrifugation study of hepatitis C virus and response to interferon therapy.
Nagasaka A; Hige S; Matsushima T; Yoshida J; Sasaki Y; Tsunematsu I; Asaka M
J Med Virol; 1997 Jun; 52(2):190-4. PubMed ID: 9179767
[TBL] [Abstract][Full Text] [Related]
13. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
Leroux-Roels G; Esquivel CA; DeLeys R; Stuyver L; Elewaut A; Philippé J; Desombere I; Paradijs J; Maertens G
Hepatology; 1996 Jan; 23(1):8-16. PubMed ID: 8550052
[TBL] [Abstract][Full Text] [Related]
14. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
[TBL] [Abstract][Full Text] [Related]
16. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
[TBL] [Abstract][Full Text] [Related]
18. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of hepatitis C viral RNA status and its correlation to antibodies to structural HCV antigens in anti-HCV reactive patients with normal liver tests.
Fong TL; Lee SR; Briggs WK; Valinluck B; Govindarajan S; Hoffman A; Jaczko B; Redeker AG
J Med Virol; 1996 Jul; 49(3):253-8. PubMed ID: 8818974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
